CBRNE - Vomiting Agents - Dm, Da, Dc Medication
- Author: Christopher P Holstege, MD; Chief Editor: Robert G Darling, MD, FACEP more...
Medication Summary
Medical therapy focuses on controlling the emesis induced by the agents. Initial antiemetic therapy may begin with routine doses of drugs commonly used to combat vomiting, such as promethazine, prochlorperazine, or droperidol. High doses of metoclopramide may be administered. If these agents are unsuccessful, 5-HT3 receptor antagonists may be administered to control nausea and vomiting. This class of drugs is comparatively expensive but well tolerated with few adverse effects. These agents include dolasetron, ondansetron, and granisetron.
Antiemetics
Class Summary
A common effect of DA, DC, and DM is emesis. Consider antiemetics in patients with persistent vomiting.
Prochlorperazine (Compazine)
May relieve nausea and vomiting by blocking postsynaptic mesolimbic dopamine receptors through anticholinergic effects and depressing reticular activating system. In addition to antiemetic effects, has advantage of augmenting hypoxic ventilatory response, acting as a respiratory stimulant at high altitude.
Promethazine (Phenergan)
For symptomatic treatment of nausea in vestibular dysfunction. Antidopaminergic agent effective in treating emesis. Blocks postsynaptic mesolimbic dopaminergic receptors in brain and reduces stimuli to brainstem reticular system.
Droperidol (Inapsine)
Neuroleptic agent that may reduce emesis by blocking dopamine stimulation of chemoreceptor trigger zone.
Metoclopramide (Reglan, Clopra, Maxolon)
Dopamine antagonist that stimulates acetylcholine release in myenteric plexus. Acts centrally on chemoreceptor triggers in floor of fourth ventricle, which provides important antiemetic activity.
5-HT3 receptor antagonists
Class Summary
A more expensive drug category compared to the other available antiemetics noted above. These agents typically are reserved for severe cases of emesis not responsive to the above medications.
Ondansetron (Zofran)
Selective 5-HT3 receptor antagonist that blocks serotonin both peripherally and centrally.
Dolasetron (Anzemet)
Selective 5-HT3 receptor antagonist that blocks serotonin both peripherally and centrally.
Granisetron (Kytril)
At chemoreceptor trigger zone, blocks serotonin peripherally on vagal nerve terminals and centrally.
Bronchodilators
Class Summary
Acute bronchospasm may result when exposure occurs to aerosolized chemicals. Bronchodilators are administered to attempt to alleviate bronchospasm that causes decreased pulmonary airflow and wheezing.
Albuterol (Ventolin, Proventil)
Beta-agonist for bronchospasm refractory to epinephrine. Relaxes bronchial smooth muscle by action on beta2-receptors with little effect on cardiac muscle contractility.
Cycloplegics
Class Summary
Eye muscarinic antagonists that cause mydriasis and alleviate ciliary spasm. May alleviate symptoms in patients who develop a chemical conjunctivitis caused by eye exposure.
Cyclopentolate (Cyclogyl, AK-Pentolate)
Prevents muscle of ciliary body and sphincter muscle of iris from responding to cholinergic stimulation. Induces mydriasis in 30-60 min and cycloplegia in 25-75 min.
Sanderson H, Fauser P, Thomsen M, Sorensen PB. Screening level fish community risk assessment of chemical warfare agents in the Baltic Sea. J Hazard Mater. Jun 15 2008;154(1-3):846-57. [Medline].
Ishii K, Tamaoka A, Otsuka F, et al. Diphenylarsinic acid poisoning from chemical weapons in Kamisu, Japan. Ann Neurol. Nov 2004;56(5):741-5. [Medline].
Kato K, Mizoi M, An Y, et al. Oral administration of diphenylarsinic acid, a degradation product of chemical warfare agents, induces oxidative and nitrosative stress in cerebellar Purkinje cells. Life Sci. Nov 10 2007;81(21-22):1518-25. [Medline].
Compton, JAF. Military Chemical and Biological Agents: Chemical and Toxicological Properties. 1988:194-204.
Ellison DH. Vomiting agents. In: Handbook of Chemical and Biological Warfare Agents. 2000:149-150.
Haas R, Tsivunchyk O, Steinbach K. Conversion of adamsite (phenarsarzin chloride) by fungal manganese peroxidase. Appl Microbiol Biotechnol. Feb 2004;63(5):564-6. [Medline].
Henriksson J, Johannisson A, Bergqvist PA, Norrgren L. The toxicity of organoarsenic-based warfare agents: in vitro and in vivo studies. Arch Environ Contam Toxicol. Feb 1996;30(2):213-9. [Medline].
Holstege CP, Bechtel LK, Reilly TH, et al. Unusual but potential agents of terrorists. Emerg Med Clin North Am. May 2007;25(2):549-66; abstract xi. [Medline].
Hu H, Somani SM, eds. Toxicodynamics of riot-control agents (lacrimators). In: Chemical Warfare Agents. 1992:271-288.
Kohler M, Hofmann K, Volsgen F. Bacterial release of arsenic ions and organoarsenic compounds from soil contaminated by chemical warfare agents. Chemosphere. Feb 2001;42(4):425-9. [Medline].
Pitten FA, Muller G, Konig P, et al. Risk assessment of a former military base contaminated with organoarsenic-based warfare agents: uptake of arsenic by terrestrial plants. Sci Total Environ. Feb 9 1999;226(2-3):237-45. [Medline].
Sidell FR. Riot control agents. In: Management of Chemical Warfare Agent Casualties. 1995:93-99.
Tornes JA, Opstad AM, Johnsen BA. Determination of organoarsenic warfare agents in sediment samples from Skagerrak by gas chromatography-mass spectrometry. Sci Total Environ. Mar 1 2006;356(1-3):235-46. [Medline].
Zajtchuck R, ed. Riot control agents. In: Textbook of Military Medicine. 1997:308-324.
Print
